NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Quick Stats
Apr 02, 202657.1
AI Score
HOLD0.23
Volume Ratio
May 21, 2026
Next Earnings
15
+ve Days (30d)
14
-ve Days (30d)
NRXP Stock Summary
Last updated Apr 02, 2026
NRXP is currently trading at $2.1899, positioned below its 200-day moving average of $2.56, suggesting bearish momentum. The stock has a 52-week range of $1.58 to $3.84.
Technical Analysis: The 50-day moving average stands at $1.95, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 58.131, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.093, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NRXP at 57.1/100 with a HOLD recommendation.
NRXP (NRX Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Apr 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 58.131 |
| CMF (20) | 0.093 |
| ROC (10) | 20.924 |
| ADX (14) | 22.545 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.078 |
| AROONOSC (14) | 14.286 |
| WILLAMS %R (14) | -34.416 |
| MFI (14) | 69.094 |
NRXP Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NRXP Price vs Max Options Open Interest
NRXP Max Change In Options Open Interest
NRXP Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NRXP Daily Out of Money Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NRXP Daily In the Money Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NRXP Most Active Options by Volume(near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NRX Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NRXP Moving Averages Analysis
NRX Pharmaceuticals, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 02, 2026
NRXP (NRX Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Apr 02, 2026
| Days | MA |
|---|---|
| 10 | 2.13 |
| 20 | 1.99 |
| 30 | 1.94 |
| 50 | 1.95 |
| 100 | 2.14 |
| 200 | 2.56 |
NRXP Fundamental Analysis
| P/E (Forward) | 2.4219 |
| P/E (Trailing) | -- |
| Market Cap ($) | 59.0 million |
| Earnings/Share ($) | -2.31 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.42 |
| EPS Estimate Next Year ($) | 0.13 |
| WallStreet Target Price ($) | 38 |
| Most Recent Quarter |